Business Paid
ASBIS invests €1 mln in a biotechnology company
01:45
ASBISc Enterprises, a leading value-added distributor, developer, and supplier of IT and IoT products, solutions, and services in the growing markets of EMEA, has agreed to acquire 20 percent of EMBIO Diagnostics for a total amount of €1 million.
EMBIO Diagnostics is a Cypriot biotechnology company that designs and develops innovative biosensor-based devices for rapid diagnostics in the field of food safety, air quality testing, and environmental research.
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
